Ilan Ganot - 02 May 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
02 May 2024
Net transactions value
-$4,772
Form type
4
Filing time
06 May 2024, 18:48:02 UTC
Previous filing
16 Feb 2024
Next filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Options Exercise +1,553 +18% 9,969 02 May 2024 Wife F1
transaction SLDB Common Stock Sale $4,772 -462 -4.6% $10.33 9,507 02 May 2024 Wife F2
holding SLDB Common Stock 94,807 02 May 2024 Direct F3
holding SLDB Common Stock 19,394 02 May 2024 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Options Exercise $0 -1,553 -100% $0.000000* 0 02 May 2024 Common Stock 1,553 Wife F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units. This sale does not represent a discretionary trade by Ms. Ganot.
F3 Represents 90,765 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F4 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F5 The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.